Congress trades in Medtronic plc. (MDT)
10 of the members we track disclosed 14 purchases of MDT between 2022-09-13 and 2026-03-27, and 30 sales. Here is what the stock did afterwards.
Every purchase is measured over the three months after the transaction date, against XLV — the ETF standing in for Healthcare & Pharma — over exactly the same dates. The second figure is the one that carries information: the first mostly reflects what the sector did. How MDT was classified.
How these buys are tagged
5 of these purchases were made by a member whose own committee oversees Healthcare & Pharma. 6 are marked Cluster: A buy is marked Cluster when at least one other tracked member of Congress bought the same stock within 30 days of it, regardless of committee membership.
| Buys | Number | Return after 3 months | vs. sector | Beat their sector |
|---|---|---|---|---|
| All buys | 14 | +0.7% | -1.8% | 64% |
| Notable (committee-flagged) | 5 | -0.1% | -7.8% | 40% |
| Unaligned (no committee overlap) | 9 | +1.1% | +1.5% | 78% |
| Cluster, excl. mega-caps | 6 | -5.9% | -2.1% | 67% |
| Not clustered, excl. mega-caps | 8 | +5.6% | -1.6% | 62% |
Who bought the most
- Richard McCormick — 2 buys
- Robert Bresnahan — 2 buys
- John James — 2 buys
- Dan Goldman — 2 buys
- Alan Armstrong — 1 buy
Every disclosed purchase
| Member | Bought disclosed |
Signal | Price | 1W | 1M | 3M | vs sector |
|---|---|---|---|---|---|---|---|
| Alan Armstrong | 2026-03-27 2026-07-21 |
Notable | $87.14 | -0.6% | -4.4% | -7.1% | -19.0% |
| Richard McCormick | 2025-11-05 2025-12-09 |
Unaligned | $90.40 | +6.0% | +12.1% | +12.7% | +5.5% |
| Robert Bresnahan | 2025-05-15 2025-05-31 |
Unaligned | $86.11 | -6.0% | +1.3% | +6.8% | +4.1% |
| Bruce Westerman | 2025-03-04 2025-04-16 |
Unaligned Cluster | $93.03 | +0.3% | -5.5% | -8.1% | +2.2% |
| Robert Bresnahan | 2025-02-25 2025-03-27 |
Unaligned Cluster | $90.48 | +2.8% | -1.7% | -10.3% | +1.0% |
| John James | 2024-06-18 2024-09-02 |
Notable | $79.75 | +0.8% | +1.8% | +11.1% | +4.5% |
| John James | 2023-11-10 2024-09-02 |
Notable | $70.68 | +5.8% | +12.3% | +20.2% | +6.2% |
| Greg Stanton | 2023-09-26 2023-11-09 |
Unaligned | $78.95 | -3.1% | -10.9% | +4.2% | -0.0% |
| Michael Guest | 2023-08-07 2023-08-23 |
Notable Cluster | $84.72 | -1.8% | -4.7% | -13.3% | -9.1% |
| Jared Moskowitz | 2023-07-14 2024-08-21 |
Unaligned Cluster | $87.65 | +1.5% | -4.8% | -17.9% | -16.8% |
| Richard McCormick | 2023-03-15 2025-09-17 |
Unaligned Cluster | $78.41 | +2.0% | +2.9% | +12.1% | +9.0% |
| Dan Goldman | 2023-03-06 2023-04-17 |
Unaligned Cluster | $81.93 | -4.8% | -2.0% | +2.2% | +0.9% |
| Dan Goldman | 2023-01-31 2023-02-24 |
Unaligned | $83.69 | +3.5% | -1.7% | +7.8% | +7.6% |
| C. Franklin | 2022-09-13 2022-10-11 |
Notable | $90.32 | -2.1% | -7.6% | -11.3% | -21.4% |
Prices are the closing price on the transaction date, not what was paid: filings never disclose an execution price. Blank figures mean the window has not elapsed yet. Sales are not scored — a sale closes a position rather than opening one — so the 30 disclosed sales of MDT are not in this table.
Download the data behind this page, or read how every figure is calculated. Trades in MDT are a small part of the full rankings, which score each member across everything they bought.
Data last updated .